Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
Draft ASEAN Equity Disclosure Standards เอกสารรับฟงความคิดเห็น เร่ือง การเปดเผยขอมูลกรณีบริษัทตางประเทศ เขามาเสนอขายหุนในประเทศไทย สํานักงาน สํานักงานคณะกรรมการกํากับหลักทรัพยและตลาดหลกัทรัพย
Equity Coverage Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) 1 of 10 Performance Overview Growth continued both revenue and net profits, attributed to efficient
Equity Coverage Central Pattana Public Company Limited Management’s Discussion and Analysis (MD&A) 1 of 10 Performance Overview Continuous growth in both revenue and net profits, attributed to
on another overseas exchange simultaneously or in proximate period, on the condition that equity trading volume on such oversea exchange is higher than that on the SET. In addition, the overseas
for non-current liabilities Employee Benefits 1,159,634.33 683,219.00 Total Non – Current liabilities 167,494,681.05 683,219.00 Total Liabilities 315,080,985.61 56,475,812.10 Shareholders' Equity Share
ที่ กบร No. Kor Bor Ror. 032/2017 November 9, 2017 President The Stock Exchange of Thailand Re : Increase of the investment proportion in the ordinary shares of Pattaya Manufacturing Co., Ltd. Dear
. Equity investors have certain property rights. For example, an equity share in a publicly traded company can be bought, sold, or transferred. An equity share https://www.sec.or.th/cgthailand/TH/Documents
1 No. LorBor. 11/2019 May 13, 2019 Re: Joint Venture in Pulp Mold Manufacturing Project Attn.: President The Stock Exchange of Thailand Kaset Thai International Sugar Corporation Public Company
% Deferred tax liabilities 17,160 17,010 1% Other liabilities 9,570 6,100 57% Total liabilities 347,509 242,401 43% Shareholder's equity Share capital 5,615 5,615 0% Share premium 60,331 60,331 0% Retained